Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Stemtech's ebitda for the twelve months ending Sep 30, 2026 was -$2.29M. For fiscal 2025 it was -$2.54M. The highest annual figure on record is -$2.04M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.54M | – |
| FY2024 | Dec 31, 2024 | -$2.04M | – |
| FY2023 | Dec 31, 2023 | -$3.64M | – |
| FY2022 | Dec 31, 2022 | -$4.58M | – |
| FY2021 | Dec 31, 2021 | -$2.78M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$329.53K | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$83.69K | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$1.05M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$822.07K | -476.8% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$297.34K | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$259.11K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$1.16M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $218.16K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$716.47K | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$686.98K | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$856.68K | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$1.27M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$420.44K | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$813.70K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.13M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$315.02K | -189.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$3.27M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$918.60K | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$73.40K | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $351.22K | – |
See a number that looks wrong?